Research Associate II - T Cell Therapeutics
Listed on 2026-01-17
-
Research/Development
Research Scientist, Clinical Research -
Healthcare
Clinical Research
Overview
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life‑threatening illnesses. The Institute's dedicated and compassionate faculty and staff are driven by a common mission:
Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting‑edge research.
City of Hope is seeking a Research Associate II to join Dr. Elizabeth Budde's T Cell Therapeutics Research Laboratories. This role involves fast‑paced research in cutting‑edge technology, immunotherapeutic programs, and a commitment to delivering innovative solutions to critical illnesses. For more information on T Cell Therapeutics research, please visit here.
As a successful candidate, you will be:- Conduct tissue culture, maintaining cell cultures and applying aseptic techniques for various cell lines, especially T cell lines.
- Perform T cell functional assays, including cytotoxicity, cytokine production assays, and ELISAs.
- Conduct cell staining for Multicolor Flow Cytometry and analyze flow cytometry data.
- Assist in murine surgical procedures, tissue harvesting/preparation, and contribute to revising/maintaining lab protocols.
- Provide routine lab support and maintain activities in accordance with Good Laboratory Practices (GLP).
- Bachelor’s degree in Biological Sciences or related field, with 2 years of post‑degree research experience, or 1 year with a Master’s degree.
- Exceptional attention to detail, accuracy in lab work, and robust record‑keeping skills.
- Preferred:
Master’s degree and hands‑on experience in cellular immunology and GLP.
City of Hope is an equal opportunity employer.
To learn more about our Comprehensive Benefits, please .
#J-18808-Ljbffr(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).